Related references
Note: Only part of the references are listed.New classifications of axillary lymph nodes and their anatomical-clinical correlations in breast surgery
Roberto Cirocchi et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI
Hung-Wen Lai et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Current Role of Intraoperative Frozen Section Examination of Sentinel Lymph Node in Early Breast Cancer
Calogero Cipolla et al.
ANTICANCER RESEARCH (2020)
Impact of BMI on HER2+metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence
Krasniqi Eriseld et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Accuracy of CEUS-guided sentinel lymph node biopsy in early-stage breast cancer: a study review and meta-analysis
Qiuxia Cui et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Efficacy of chemotherapy for lymph node-positive luminal A subtype breast cancer patients: an updated meta-analysis
Yilun Li et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era
Yue Liang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer
Hideo Shigematsu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success
Marina Elena Cazzaniga et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment
Marleen M. Roos et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study
Liulu Zhang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
The clinical implication of the number of lymph nodes harvested during sentinel lymph node biopsy and its effects on survival outcome in patients with node-negative breast cancer
Mi Kyoung Kim et al.
AMERICAN JOURNAL OF SURGERY (2017)
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study
Marissa C. van Maaren et al.
LANCET ONCOLOGY (2016)
Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients
Giuseppe Caruso et al.
ACTA RADIOLOGICA (2014)
Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM 048/13/2000
Montserrat Sola et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Viviana Galimberti et al.
LANCET ONCOLOGY (2013)
How Many Sentinel Lymph Nodes Are Enough for Accurate Axillary Staging in T1-2 Breast Cancer?
Eun Jeong Ban et al.
JOURNAL OF BREAST CANCER (2011)
Effect of Occult Metastases on Survival in Node-Negative Breast Cancer
Donald L. Weaver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag et al.
LANCET ONCOLOGY (2010)
The value of intraoperative frozen section examination of sentinel lymph nodes in surgical management of breast carcinoma
Calogero Cipolla et al.
LANGENBECKS ARCHIVES OF SURGERY (2010)
Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature
I. M. C. van der Ploeg et al.
EJSO (2008)
The Accuracy of Sentinel Lymph Node Biopsy in the Treatment of Multicentric Invasive Breast Cancer Using a Subareolar Injection of Tracer
Calogero Cipolla et al.
WORLD JOURNAL OF SURGERY (2008)
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
David N. Krag et al.
LANCET ONCOLOGY (2007)
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer
U Veronesi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
B Fisher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
